Company: ZLAB
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001628280-25-008409
Chunk: 61

Company: Zai Lab Ltd
Filing Date: 2025-02-27
Form: 10-K
Item: Item 16
Chunk 61
---
 280, the Company has only one reportable segment. The following tables present disaggregated expenses that are regularly provided to the CODM:Year Ended December 31,202420232022Selling and marketing expenses190,367 169,555 159,136 General and administrative expenses108,374 112,053 99,835 Total selling, general, and administrative expenses298,741 281,608 258,971 

F-37

Zai Lab LimitedNotes to the consolidated financial statements For the years ended December 31, 2022, 2023 and 2024 

Year Ended December 31,202420232022Personnel compensation and related costs106,154 115,749 105,561 Licensing fees30,997 19,291 53,441 CROs/CMOs/Investigators expenses69,870 103,333 100,544 Other costs27,483 27,495 26,862 Total research and development expenses234,504 265,868 286,408 Year Ended December 31,202420232022Clinical programs86,126 112,158 155,792 Pre-clinical programs31,913 17,356 6,644 Unallocated research and development expenses116,465 136,354 123,972 Total research and development expenses234,504 265,868 286,408 Year Ended December 31,202420232022Personnel compensation and related costs174,958 173,389 162,045 Other costs123,783 108,219 96,926 Total selling, general, and administrative expenses298,741 281,608 258,971 

22.    Subsequent Events 

In January 2025, the Company identified an additional opportunity to access capital denominated in RMB through a debt facility with Bank of Communications on favorable commercial terms to support its working capital needs in mainland China. As a result, on January 2, 2025, the Company entered into a guarantee contract with Bank of Communications Co., Ltd. Shanghai Zhangjiang Sub-Branch (“BOCOM”) pursuant to which the Company will guarantee working capital loans from BOCOM to Zai Lab Shanghai, and Zai Lab Shanghai entered into a working capital loan contract with BOCOM with respect to a revolving credit facility of up to RMB300.0 million (approximately $41.1 million), of which